FREDUN
NSEFREDUN
Key statistics
- Open
- ₹1,361.10
- Day range
- 1,338.00 – 1,388.00
- 52-week range
- —
- From 52w high
- —
- Volume
- 65.0K
- Turnover
- ₹8.8Cr
- Delivery
- 58.8%
- Rel volume
- 1.00×
- RSI (14)
- 45.6
- ATR (14)
- 70.22
- SMA 50
- —
- SMA 200
- —
20-day avg 51.8%
Performance
- 1 day
- -0.27%
- 1 week
- +4.07%
- 1 month
- -9.22%
- 3 months
- —
- 6 months
- —
- 1 year
- —
Delivery percentage
- Latest
- 58.8%
- 20-day avg
- 51.8%
- 1-year avg
- 53.5%
- Percentile
- 66th
- Range
- 38.3–67.7%
25 Sept 2026
Against its own sessions
29 sessions
Over the last 20 sessions FREDUN settled 51.8% of its traded quantity, which is above average for an NSE equity.
What delivery percentage measuresScan the whole market on delivery
Fundamentals
- Market cap
- ₹2,244 Cr
- P/E (TTM)
- —
- EPS (TTM)
- —
- Shares outstanding
- —
- Listed
- 17 Aug 2026
no positive TTM earnings
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growth
- Revenue YoY
- —
- Profit YoY
- —
- Revenue QoQ
- —
- Profit QoQ
- —
- Interest cost YoY
- —
Compound growth
Not enough filed history for a compound growth rate yet.
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE194R01017
- Series
- EQ
- History from
- 17 Aug 2026
- Sessions
- 29
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.